NHSA Concludes 2024 NRDL Review, Announces Submission Deadlines for Drug Manufacturers
The National Healthcare Security Administration (NHSA) has declared the completion of the expert review process...
NHSA (prev. SMIA)
China’s NHSA and MOF Issue Notices to Enhance Cross-Regional Medical Treatment Direct Settlement
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MOF) have issued two...
China’s NHSA Proposes New Guidelines to Enhance Oversight of Medical Insurance Funds
The National Healthcare Security Administration (NHSA) has unveiled a draft of the “Guiding Opinions on...
China to Enhance Basic Medical Insurance Coverage for Residents in 2024 with Increased Subsidies and Personal Payments
The National Healthcare Security Administration (NHSA), in conjunction with the Ministry of Finance and State...
NHSA Flags Concerns Over Pricing of MicroPort’s Castor Aortic Stent Graft System
BEIJING—The National Healthcare Security Administration (NHSA) has issued an open letter expressing concerns over the...
NHSA Preliminary Review Identifies Potential NRDL Additions, Including Novel Therapies and ADCs
The National Healthcare Security Administration (NHSA) has released a preliminary list of drugs that have...
China’s NHSA and NHC to Integrate Village Clinics into Basic Medical Insurance System
The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC) of China have...
NHSA Report: China’s Medical Insurance Fund Records Significant Growth and Savings in 2023
The National Healthcare Security Administration (NHSA) has released its comprehensive annual statistical report for the...
China’s NHSA Updates DRG/DIP Payment Reform Program with New Exclusion Mechanisms and Timelines
The National Healthcare Security Administration (NHSA) in China has issued a notification outlining several updates...
NHSA Mandates Standardized Online Procurement for Injectable Drugs to Ensure Pricing Transparency
The National Healthcare Security Administration (NHSA) has issued a directive to standardize the procurement process...
LG Chem and Yifan Pharmaceutical Launch Hyruan ONE for Knee Osteoarthritis in China
LG Chem, a leading chemical company based in South Korea, and Yifan Pharmaceutical Co., Ltd...
China’s NHSA Releases 2024 National Reimbursement Drug List Adjustment Plan
The National Healthcare Security Administration (NHSA) has published the National Reimbursement Drug List (2024) adjustment...
NHSA Seeks Public Input on National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has unveiled the adjustment plan for the National Reimbursement...
China’s NHSA and MoF Plan Expansion of Long-term Care Insurance System Pilot Program
The National Healthcare Security Administration (NHSA) and the Ministry of Finance (MoF) have jointly issued...
Shenzhen’s Draft Proposal for VBP Drug Procurement and Medical Insurance Fund Management Released
The Healthcare Security Administration (HSA) Bureau of the Shenzhen municipality has released a “Shenzhen Drug...
NMPA Announces Digitalization of Medical Device Regulatory Documents
The National Medical Products Administration (NMPA) has announced a transition to digitalize regulatory documentation for...
China’s NHSA Launches New Procedures for Drug Catalogue Attribution Identification
The National Healthcare Security Administration (NHSA) has issued the “Procedures for Identification of Drug and...
China Unveils Comprehensive Plan to Tackle Unhealthy Practices in Pharma and Healthcare
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA),...
Beijing Unveils Action Plan to Boost Pharmaceutical and Health Industry by 2026
The Beijing People’s Government has issued an “Action Plan” outlining measures and targets to “Accelerate...
China’s NHSA Aims to Boost Medical Insurance Reform with Sanming Model
The National Healthcare Security Administration (NHSA) has issued a notification aimed at promoting the medical...